लोड हो रहा है...
Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation
Inflammatory myofibroblastic tumor (IMT), a rare sarcoma, is primarily treated via resection of the mass. However, in cases of recurrence or unresectable tumors, no standard care exists. While crizotinib, an anaplastic lymphoma kinase (ALK) inhibitor, is only approved for non-small-cell lung cancer...
में बचाया:
| में प्रकाशित: | Intern Med |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
The Japanese Society of Internal Medicine
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478978/ https://ncbi.nlm.nih.gov/pubmed/30449794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1640-18 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|